Leadless Pacing: Current State and Future Direction
نویسندگان
چکیده
منابع مشابه
Leadless Pacing: Current State and Future Direction
Leadless pacing is now an established alternative to conventional pacing with subcutaneous pocket and transvenous lead for patients with class I or II single-chamber pacing indication. Available 12-month follow-up data shows a 48% fewer major complication rate in patients with Micra™ compared to a historical control group in a nonrandomized study [1]. There is one system with Food and Drug Admi...
متن کاملState of the art of leadless pacing.
Despite undisputable benefits, conventional pacemaker therapy is associated with specific complications related to the subcutaneous device and the transvenous leads. Recently, two miniaturized leadless pacemakers, Nanostim™ (St. Jude Medical) and Micra™ (Medtronic), which can be completely implanted inside the right ventricle using steerable delivery systems, entered clinical application. The W...
متن کاملLeadless cardiac pacing
Transvenous cardiac pacemakers definitely improve quality of life and reduce mortality in at-risk patients, but they are associated with several potential device-related complications. Approximately 10% of patients experience complications related to transvenous implantation of the pacemaker. These may be attributable to either the pulse generator (hematoma, skin breakdown, pocket infection) or...
متن کاملThe human proteome project: current state and future direction.
After the successful completion of the Human Genome Project, the Human Proteome Organization has recently officially launched a global Human Proteome Project (HPP), which is designed to map the entire human protein set. Given the lack of protein-level evidence for about 30% of the estimated 20,300 protein-coding genes, a systematic global effort will be necessary to achieve this goal with respe...
متن کاملPermanent leadless cardiac pacing: results of the LEADLESS trial.
BACKGROUND Conventional cardiac pacemakers are associated with several potential short- and long-term complications related to either the transvenous lead or subcutaneous pulse generator. We tested the safety and clinical performance of a novel, completely self-contained leadless cardiac pacemaker. METHODS AND RESULTS The primary safety end point was freedom from complications at 90 days. Sec...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cardiology and Therapy
سال: 2017
ISSN: 2193-8261,2193-6544
DOI: 10.1007/s40119-017-0097-3